The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats

Overview of attention for article published in Cardiovascular Diabetology, April 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 133 Dimensions

Readers on

mendeley: 147 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 44,496 followers.

RT @a_l_bailey: @HeartOTXHeartMD @bjcohenmd @saraceciliamtz @JJheart_doc @shelleyhallmd Agree with @HeartOTXHeartMD (as usual!) #SGLT2i hav…

Reply Repost Favourite

RT @a_l_bailey: @HeartOTXHeartMD @bjcohenmd @saraceciliamtz @JJheart_doc @shelleyhallmd Agree with @HeartOTXHeartMD (as usual!) #SGLT2i hav…

Reply Repost Favourite

@HeartOTXHeartMD @bjcohenmd @saraceciliamtz @JJheart_doc @shelleyhallmd Agree with @HeartOTXHeartMD (as usual!) #SGLT2i have many mechanisms that can modify outcomes. Still learning about these but alteration of negative LV remodeling likely involved. I

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.